DHCR24 knockdown-induced cellular cholesterol deficiency triggers tau hyperphosphorylation at Thr181, Ser199 and Ser202/Thr205 via p38 MAPK/JNK signaling
Cellular Signalling · 2026
DOI: 10.1016/j.cellsig.2025.112254 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cellular Signalling, 2026. Verfasst von Mengqi Zhang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Huadong Hospital Affiliated with Fudan University, Shanghai 200040, China; Department of Neurology, Jinshan Hospital Affilia…. Hauptthemen laut MEDLINE: tau Proteins, Cholesterol, p38 Mitogen-Activated Protein Kinases, Oxidoreductases Acting on CH-CH Group Donors. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shanghai Key Discipline Construction Project.
Abstract (Originalsprache)
Cholesterol deficiency is implicated in Alzheimer's disease (AD) pathogenesis, yet its regulatory role in tau phosphorylation remains unclear. We investigated whether the loss of 24-dehydrocholesterol reductase (DHCR24), a key enzyme in cholesterol biosynthesis, drives tau hyperphosphorylation via p38 MAPK and JNK signaling pathways in SH-SY5Y neuroblastoma cells. Using lentiviral vectors encoding DHCR24-cDNA or DHCR24-shRNA, we established stable DHCR24-overexpression and DHCR24-knockdown SH-SY5Y cell models. Filipin III staining and UPLC-MS/MS demonstrated that DHCR24 knockdown significantly reduced cellular cholesterol levels, whereas overexpression raised cholesterol levels. Immunoblotting showed selective increases in tau phosphorylation at Thr181, Ser199, and Ser202/Thr205 via DHCR24 deficiency; total tau levels remained unchanged. Concomitantly, phospho-p38 and phospho-JNK levels increased by 1.5- to 2.5-fold without alterations in total kinase levels, indicating pathway activation. To test causality, DHCR24-silenced cells were treated with escalating doses of the p38 inhibitor SB203580 (0-40 μM) or the JNK inhibitor SP600125 (0-40 μM). Both compounds restored tau phosphorylation to baseline in a concentration-dependent manner, with maximal suppression at 40 μM (SB203580) and 20-40 μM (SP600125). Collectively, these data establish DHCR24-controlled cholesterol homeostasis as a molecular rheostat of tau pathology through p38/JNK signaling, and nominate this axis for therapeutic intervention in AD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Huadong Hospital Affiliated with Fudan University, Shanghai 200040, China; Department of Neurology, Jinshan Hospital Affiliated with Fudan University, Shanghai 201508, China.
- Department of Neurology, Huadong Hospital Affiliated with Fudan University, Shanghai 200040, China. Electronic address: wenshiwei1994@163.com.
- Department of Neurology, Jinshan Hospital Affiliated with Fudan University, Shanghai 201508, China. Electronic address: hbzyy666@163.com.
Förderung
- Shanghai Key Discipline Construction Project
Zitieren
APA
Zhang, M., Wei, W., & Zu, H. (2026). DHCR24 knockdown-induced cellular cholesterol deficiency triggers tau hyperphosphorylation at Thr181, Ser199 and Ser202/Thr205 via p38 MAPK/JNK signaling. Cellular Signalling. https://doi.org/10.1016/j.cellsig.2025.112254
Vancouver
Zhang M, Wei W, Zu H. DHCR24 knockdown-induced cellular cholesterol deficiency triggers tau hyperphosphorylation at Thr181, Ser199 and Ser202/Thr205 via p38 MAPK/JNK signaling. Cellular Signalling. 2026. doi:10.1016/j.cellsig.2025.112254
BibTeX
@article{Zhang2026,
author = {Zhang, Mengqi and Wei, Wenshi and Zu, Hengbing},
title = {DHCR24 knockdown-induced cellular cholesterol deficiency triggers tau hyperphosphorylation at Thr181, Ser199 and Ser202/Thr205 via p38 MAPK/JNK signaling},
journal = {Cellular Signalling},
year = {2026},
doi = {10.1016/j.cellsig.2025.112254}
}
EUVIMED